XML 118 R109.htm IDEA: XBRL DOCUMENT v3.23.2
Income Taxes - Additional Information (Detail) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Sep. 30, 2021
Dec. 31, 2019
Income Tax Disclosure [Line Items]            
Income tax benefit, result of CARES act of 2020       $ 10,800,000    
Valuation allowance established against deferred tax assets       7,900,000    
Tax rate differential on carrying back losses amount       $ 2,900,000    
US corporate tax rate       35.00%    
Federal tax rate   21.00% 21.00% 21.00%    
Income tax expense, result of Alabama business tax competitiveness act $ 1,600,000          
Deferred tax asset, research and development credit carryforwards   $ 64,995,000 $ 21,606,000      
Deferred tax expense recorded as an adjustment to other comprehensive (loss) income   2,000,000 1,600,000      
Deferred tax assets, gross   11,411,000 59,643,000      
Valuation allowance established against deferred tax assets   5,201,000 50,564,000      
Deferred tax assets tax credit carryforward net operating loss and research and development   2,000,000        
Decrease in valuation allowance   (45,400,000)        
Net of deferred tax liabilities   6,210,000 9,079,000      
Foreign and domestic loss carry-forwards, research and development tax credits, unamortized research and development cost and state credit carry-forwards   $ 104,500,000 39,700,000      
Operating loss carry forwards expiration year   2038        
Deferred tax assets   $ 130,457,000 18,708,000      
Cash and cash equivalents   108,644,000 56,603,000      
Short-term investments (includes $340 and $350 of available-for-sale securities as of December 31, 2022 and 2021, respectively, reported at fair value)   340,000 350,000      
Short-term liquidity amount   108,900,000 57,000,000      
Withholding tax liabilities in jurisdiction   400,000 700,000      
Income tax benefit (expense) from stock options exercised adjustment to equity   0 0 $ 0    
Unrecognized tax benefits   17,885,000 17,836,000 1,078,000   $ 1,487,000
Unrecognized tax benefits, effective tax rate   17,900,000 17,800,000 1,000,000    
Accrued interest and penalties   100,000 200,000 $ 300,000    
Foreign Subsidiaries [Member]            
Income Tax Disclosure [Line Items]            
Short-term liquidity amount   $ 86,300,000 $ 47,700,000      
Short-term liquidity, in percentage   79.00% 84.00%      
Operating Losses Expiration Between 2023 and 2041 [Member]            
Income Tax Disclosure [Line Items]            
Deferred tax assets   $ 21,800,000        
Minimum [Member]            
Income Tax Disclosure [Line Items]            
Operating loss carry forwards expiration year   2023        
Maximum [Member]            
Income Tax Disclosure [Line Items]            
Operating loss carry forwards expiration year   2038        
IRS [Member]            
Income Tax Disclosure [Line Items]            
Income tax refund receivable         $ 15,200,000  
Deferred tax asset, research and development credit carryforwards         1,800,000  
Unrecognized tax benefits         $ 17,000,000  
Domestic [Member]            
Income Tax Disclosure [Line Items]            
Deferred tax assets, gross   $ 61,726,000 $ 48,265,000      
Valuation allowance established against deferred tax assets   3,177,000 $ 48,265,000      
Current valuation allowance established against deferred tax assets   3,200,000        
Deferred tax assets   $ 58,549,000